Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Evexia Lifecare
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 24.78 | 14.02 | 10.65 | 6.75 | 24.72 | 21.23 | 26.71 | 21.70 | 23.61 | 22.09 | 25.73 | 25.24 | 36.79 |
| Expenses + | 24.92 | 13.83 | 12.01 | 6.76 | 21.66 | 20.93 | 25.62 | 21.53 | 22.29 | 21.01 | 25.63 | 24.99 | 35.69 |
| Operating Profit | -0.14 | 0.19 | -1.36 | -0.01 | 3.06 | 0.30 | 1.09 | 0.17 | 1.32 | 1.08 | 0.10 | 0.25 | 1.10 |
| OPM % | -0.56% | 1.36% | -12.77% | -0.15% | 12.38% | 1.41% | 4.08% | 0.78% | 5.59% | 4.89% | 0.39% | 0.99% | 2.99% |
| Other Income + | 0.18 | 0.20 | -0.20 | 0.00 | 0.86 | 0.13 | 0.00 | 0.10 | 0.00 | 0.00 | 0.43 | 0.26 | 0.10 |
| Interest | 0.52 | 0.00 | 0.01 | -0.01 | 0.49 | 0.00 | 0.05 | 0.00 | 0.41 | 0.01 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.10 | 0.10 | 0.10 | 0.07 | 0.15 | 0.10 | 0.11 | 0.11 | 0.46 | 0.21 | 0.03 | 0.12 | 0.30 |
| Profit before tax | -0.58 | 0.29 | -1.67 | -0.07 | 3.28 | 0.33 | 0.93 | 0.16 | 0.45 | 0.86 | 0.50 | 0.39 | 0.90 |
| Tax % | 41.38% | 27.59% | 0.00% | -28.57% | 16.77% | 24.24% | 0.00% | 25.00% | 31.11% | 25.58% | 28.00% | 25.64% | 13.33% |
| Net Profit + | -0.83 | 0.22 | -1.67 | -0.05 | 2.73 | 0.24 | 0.94 | 0.12 | 0.31 | 0.63 | 0.37 | 0.29 | 0.78 |
| EPS in Rs | -0.01 | 0.00 | -0.03 | -0.00 | 0.04 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Financials of Evexia Lifecare
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1 | 34 | 178 | 74 | 105 | 100 | 107 | 76 | 70 | 56 | 87 | 110 |
| Expenses + | 1 | 34 | 176 | 74 | 106 | 107 | 179 | 73 | 69 | 54 | 85 | 107 |
| Operating Profit | -0 | -0 | 1 | -0 | -1 | -6 | -72 | 2 | 1 | 2 | 2 | 3 |
| OPM % | -8% | -0% | 1% | -0% | -1% | -6% | -68% | 3% | 1% | 3% | 2% | 3% |
| Other Income + | 0 | 1 | 0 | 1 | 3 | 12 | 74 | 0 | 2 | 1 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Profit before tax | 0 | 0 | 1 | 1 | 2 | 5 | 2 | 2 | 2 | 2 | 1 | 2 |
| Tax % | 31% | 41% | 32% | 33% | 30% | 29% | 33% | 60% | 56% | 28% | 55% | 26% |
| Net Profit + | 0 | 0 | 1 | 0 | 2 | 3 | 1 | 1 | 1 | 1 | 0 | 2 |
| EPS in Rs | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | 0.06 | 0.02 | 0.01 | 0.01 | 0.02 | 0.00 | 0.01 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Evexia Lifecare
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 46 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 66 | 71 | 188 | 188 |
| Reserves | 19 | 3 | 4 | 11 | 13 | 16 | 18 | 19 | 24 | 59 | 272 | 379 |
| Borrowings + | 5 | 11 | 6 | 6 | 4 | 7 | 7 | 6 | 705 | 686 | 386 | 1,222 |
| Other Liabilities + | 4 | 35 | 147 | 128 | 146 | 139 | 56 | 41 | 52 | 67 | 75 | 65 |
| Total Liabilities | 74 | 112 | 219 | 208 | 224 | 224 | 142 | 127 | 848 | 883 | 920 | 1,853 |
| Fixed Assets + | 2 | 2 | 2 | 9 | 9 | 9 | 9 | 9 | 11 | 11 | 50 | 14 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 1 |
| Investments | 4 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 704 | 724 | 717 | 879 |
| Other Assets + | 68 | 109 | 216 | 199 | 216 | 215 | 132 | 115 | 132 | 148 | 154 | 959 |
| Total Assets | 74 | 112 | 219 | 208 | 224 | 224 | 142 | 127 | 848 | 883 | 920 | 1,853 |
Financials of Evexia Lifecare
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 4 | 11 | -116 | -12 | -0 | -3 | 2 | -6 | -3 | 17 | -2 | -23 |
| Cash from Investing Activity + | 0 | 2 | 1 | -6 | 0 | 1 | -2 | 8 | -697 | -17 | -18 | 53 |
| Cash from Financing Activity + | -4 | -12 | 113 | 18 | 0 | 2 | 1 | -1 | 699 | 1 | 20 | -28 |
| Net Cash Flow | 1 | 1 | -2 | -0 | 0 | -0 | 0 | 1 | -1 | 0 | -0 | 2 |
| Free Cash Flow | 4 | 11 | -116 | -18 | -0 | -3 | 2 | -8 | -6 | 17 | -2 | -27 |
| CFO/OP | -8,200% | -9,864% | -9,145% | 3,357% | -44% | 52% | -3% | -152% | -184% | 910% | -194% | -818% |
Financials of Evexia Lifecare
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 983 | 237 | 286 | 174 | 197 | 249 | 156 | 73 | 164 | 282 | 392 | |
| Inventory Days | 197 | 5 | 2 | 3 | 3 | 2 | 12 | 7 | 11 | 8 | 12 | |
| Days Payable | 187 | 384 | 73 | 67 | 158 | 172 | 114 | 124 | 186 | 195 | 280 | |
| Cash Conversion Cycle | 993 | -142 | 215 | 109 | 42 | 80 | 54 | -44 | -11 | 95 | 123 | |
| Working Capital Days | -1,578 | 248 | 250 | 278 | 134 | 245 | 192 | 175 | 207 | 343 | 143 | |
| ROCE % | 0% | 2% | 1% | 3% | 6% | 2% | 3% | 0% | 0% | 0% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…